Related Experiment Video
Updated: Apr 8, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Torin 1 partially corrects vigabatrin-induced mitochondrial increase in mouse
Kara R Vogel1, Garrett R Ainslie1, Erwin E W Jansen2
1Section of Experimental and Systems Pharmacology, College of Pharmacy, Washington State University Spokane, Washington.
Vigabatrin, an epilepsy drug, increases GABA levels, leading to more mitochondria and cell death by activating mTOR. Torin 1, an mTOR inhibitor, reversed these effects in mice.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Supraphysiological GABA (4-aminobutyric acid) has been linked to mechanistic target of rapamycin (mTOR) activation and mitophagy disruption.
- Vigabatrin is an antiepileptic drug that elevates central nervous system GABA levels.
Purpose of the Study:
- To investigate if vigabatrin intervention causes similar outcomes as observed with GABA metabolic enzyme deletion.
- To examine the effects of vigabatrin on mitochondrial biogenesis and cell death pathways.
Main Methods:
- Biochemical assays
- Electron microscopy
- Pharmacological intervention with vigabatrin and Torin 1 in mice
Main Results:
- Vigabatrin administration significantly increased mitochondrial numbers and areas in mice.
- These mitochondrial changes were normalized by Torin 1, an mTOR inhibitor.
- Short-term vigabatrin treatment induced apoptosis and enhanced mTOR phosphorylation (Ser 2448) in the liver.
Conclusions:
- Vigabatrin intervention is associated with increased mitochondrial biogenesis in central and peripheral tissues.
- This mitochondrial expansion may be linked to mechanistic target of rapamycin (mTOR) pathway activation.
- Vigabatrin administration may promote cell death through mTOR-mediated pathways.
More Related Videos
06:56Near Infrared NIr Light Increases Expression of a Marker of Mitochondrial Function in the Mouse Vestibular Sensory Epithelium
Published on: March 14, 2015
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011